SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-061579
Filing Date
2013-08-08
Accepted
2013-08-08 13:10:26
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13746_110q.htm 10-Q 1159182
2 EX-31.1 a13-13746_1ex31d1.htm EX-31.1 11637
3 EX-31.2 a13-13746_1ex31d2.htm EX-31.2 11648
4 EX-32.1 a13-13746_1ex32d1.htm EX-32.1 5551
5 EX-32.2 a13-13746_1ex32d2.htm EX-32.2 5562
  Complete submission text file 0001104659-13-061579.txt   11133478

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20130630.xml EX-101.INS 975346
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mack-20130630.xsd EX-101.SCH 107453
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mack-20130630_cal.xml EX-101.CAL 60197
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mack-20130630_def.xml EX-101.DEF 490022
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mack-20130630_lab.xml EX-101.LAB 1503459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mack-20130630_pre.xml EX-101.PRE 817659
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 131021019
SIC: 2834 Pharmaceutical Preparations